glp 1 receptor agonist moa GLP-1 Agonists as Treatments for Type 2 Diabetes GLP1 Receptor Agonists—Effects beyond Obesity
Description
doi:10.1001/jama.2017.14752 42
Liu BD, Udemba SC, Liang K, Tarabichi Y, Hill H, Fass R, et al
Increasing fiber intake gradually, staying hydrated, and using probiotics may help
Conversely, the first line treatment for IIH, acetazolamide, has little to no effect on weight loss ( Table 2 ) (16)
More significantly, GLP-1RAs have been shown in large, randomized CV outcome trials (CVOTs) to lower CVD in patients with type 2 diabetes (34)
